HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients.

Abstract
Endothelin-1 (ET-1) seems to enhance the pro-fibrotic protein synthesis by skin fibroblasts and its effects are mediated by endothelin-A and B (ETA and ETB) receptors. This study aimed to investigate the effects of ETA and ETB receptor antagonists (ETARA-sitaxsentan and ETA/BRA-bosentan) on type I collagen (COL-1), fibronectin (FN) and fibrillin-1 (FBL-1) synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients. Primary cultures of fibroblasts were obtained from skin biopsies of 6 female systemic sclerosis patients and were treated with ET-1 (100 nM) for 24 and 48 hrs with or without pre-treatment (1 hr) with ETARA (2 μM) or ETA/BRA (10 μM). Primary culture of human scleroderma skin fibroblasts not treated with ET-1 or ET receptor antagonists (ETARA and ETA/BRA) were used as controls. COL-1, FN and FBL-1 synthesis was evaluated by immunocytochemistry and Western blot analysis. Immunocytochemistry and Western blot analysis showed that ET-1 significantly increased COL-1 and FN synthesis at 24 and 48 hrs and FBL-1 synthesis at 48 hrs vs untreated cells. ETARA significantly contrasted the ET-1-mediated increase in COL-1 and FN at 24 hrs as well as COL-1 and FBL-1 at 48 hrs, but not FN synthesis vs ET-1-treated fibroblasts. Conversely, ETA/BRA significantly antagonized the ET-1-mediated overproduction of COL-1 and FN both at 24 and 48 hrs and the FBL-1 synthesis at 48 hrs vs ET-1-treated cells. The single ETARA treatment seems to contrast significantly the increase in COL-1 synthesis, whereas the dual ETA/BRA treatment seems active in significantly antagonizing both COL-1 and FN overproduction induced by ET-1. In conclusion, ET-1 antagonism might have positive effects in contrasting the profibrotic activity of systemic sclerosis skin fibroblasts.
AuthorsS Soldano, P Montagna, R Brizzolara, C Ferrone, A Parodio, A Sulli, B Seriolo, B Villaggio, M Cutolo
JournalReumatismo (Reumatismo) Vol. 64 Issue 5 Pg. 326-34 (Dec 11 2012) ISSN: 0048-7449 [Print] Italy
PMID23256109 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Collagen Type I
  • Endothelin A Receptor Antagonists
  • Endothelin B Receptor Antagonists
  • Extracellular Matrix Proteins
  • FBN1 protein, human
  • Fibrillin-1
  • Fibrillins
  • Fibronectins
  • Isoxazoles
  • Microfilament Proteins
  • Sulfonamides
  • Thiophenes
  • sitaxsentan
  • Bosentan
Topics
  • Aged
  • Bosentan
  • Cells, Cultured
  • Collagen Type I (biosynthesis)
  • Endothelin A Receptor Antagonists
  • Endothelin B Receptor Antagonists
  • Extracellular Matrix Proteins (biosynthesis)
  • Female
  • Fibrillin-1
  • Fibrillins
  • Fibroblasts (drug effects, metabolism)
  • Fibronectins (biosynthesis)
  • Fibrosis
  • Humans
  • Isoxazoles (pharmacology)
  • Microfilament Proteins (biosynthesis)
  • Middle Aged
  • Primary Cell Culture
  • Scleroderma, Systemic (metabolism, pathology)
  • Sulfonamides (pharmacology)
  • Thiophenes (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: